デフォルト表紙
市場調査レポート
商品コード
1782005

ELISA診断検査の世界市場：検査の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

ELISA Diagnostics Tests Market, By Test Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
ELISA診断検査の世界市場：検査の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

レポートのハイライト

ELISA診断検査の市場規模は2024年に16億9,032万米ドルとなり、2025年から2032年にかけてCAGR 5.93％で拡大

ELISA診断検査の市場力学

疾病負担の増大が早期診断の需要を高める

世界の感染症や慢性疾患の増加により、早期かつ正確な診断法の必要性が高まっています。ELISA検査は、疾患の初期段階で特定のタンパク質、抗原、抗体を検出できるため、極めて重要です。Thermo Fisher Scientific社やBio-Rad Laboratories社などの企業は、HIVの早期検出にELISAキットを一般的に使用しています。これは患者の転帰を改善し、感染を減らすのに役立ちます。COVID-19パンデミックの際、アボット社は先行感染を特定するためにELISAベースの抗体検査を開発しました。これは公衆衛生活動を支援し、ワクチン配布に役立ちました。さらにBio-Techne社は、PSAやCA-125のようながんバイオマーカーのELISAキットを提供しています。これらのキットは早期診断と治療モニタリングに役立っています。これらの例は、疾病数の増加がELISA診断検査に対する世界の需要をいかに増大させているかを示しています。ヘルスケアシステムは、疾患の早期発見と管理のために、高感度で手頃な価格の信頼性の高いツールに注目しています。

例えば、2021年10月、シーメンス・ヘルスイニアーズは、関節リウマチやループスのような疾患の世界の有病率の上昇に対応し、自己免疫疾患の早期発見のために設計された新しいELISAベースのアッセイを発売しました。この発売は、臨床医がこれらの複雑な疾患を早期に診断し、患者管理を改善するのに役立ちます。

ELISA診断検査市場 - 主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約5.93%のCAGRで毎年成長すると予測されています。

検査の種類別に見ると、サンドイッチELISAが2024年に最大市場シェアを示すと予測されました。

用途別では、感染症が2024年の主要用途でした。

地域別では、北米が2024年に主要な収益源となりました。

ELISA診断検査市場：セグメンテーション分析

世界のELISA診断検査市場は、検査の種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は検査の種類により、競合ELISA、間接ELISA、マルチプル・ポータブルELISA、サンドイッチELISAの4つに分類されます。市場を独占しているのはサンドイッチELISA分野です。これは、他のELISA形式と比較して感度と特異性が優れているためです。この方法では、2層の抗体の間に標的抗原を取り込むため、血液や血清のような複雑なサンプル中の低濃度のバイオマーカーの検出精度が向上します。このような利点から、サンドイッチELISAは臨床診断において、感染症検出、がんバイオマーカー同定、ホルモン濃度測定など幅広い用途に広く用いられています。その信頼性と定量結果を提供する能力により、ヘルスケアプロバイダーや研究機関の間で好んで使用されています。

市場はエンドユーザーによって、病院・診断センター、製薬・バイオテクノロジー企業、動物病院・診断検査室の3つのカテゴリーに分けられます。病院・診断センターが市場を独占しています。この優位性は、病気の診断、モニタリング、スクリーニングのために臨床現場でELISA検査が広く使用されていることによる。病院および診断センターは、感染症、慢性疾患、その他の健康上の懸念を管理するために、信頼性が高く迅速な検査ソリューションを必要としており、ELISAキットおよび関連製品の最大の消費者となっています。高精度で高スループットの診断ツールに対する継続的な需要により、この分野は製薬会社や動物診断研究所と比較して最大の市場シェアを占めています。

ELISA診断検査市場 - 地域別分析

2024年の予測期間中、北米が世界のELISA診断検査市場を独占しています。

北米はELISA診断検査市場で最大のシェアを占めています。これは主に、強力なヘルスケアインフラと大量の診断検査によるものです。同地域は、医学研究や公衆衛生に対する政府および民間部門の多額の投資による恩恵を受けています。Thermo Fisher Scientific社、Abbott社、Bio-Rad Laboratories社などの大手企業が、継続的な技術革新を推進し、高品質のELISAキットや機器を提供しています。米国およびカナダの病院や研究所では、さまざまな感染症や慢性疾患の診断にELISA検査が一般的に使用されています。さらに、疾患の早期発見に対する高い意識と有利な償還政策が、これらの検査の普及を支えています。これらの要因が相まって、北米はこの市場の主要地域となっています。

アジア太平洋は、2024年の市場推計・予測期間中、ELISA診断検査市場で最も高いCAGRを記録すると推定されます。

ELISA診断検査市場は、アジア太平洋が最も急速に成長しています。この成長は感染症や生活習慣病の増加によるものです。中国、インド、東南アジア諸国などの国々は、ヘルスケアインフラを拡大し、診断技術への投資を増やしています。早期診断の重要性に対する医療従事者や一般市民の意識が高まっており、ELISAベースの検査に対する需要が高まっています。政府の健康への取り組みや大規模なスクリーニング・プログラムも、ELISAのような信頼性の高い診断ツールの使用を促進しています。さらに、ELISAキットは低コストであるため、予算重視のヘルスケア環境において人気の高い選択肢となっています。これらの要因が、同地域における市場の大幅な成長を後押ししています。

ELISA診断検査市場：競合情勢

ELISA診断検査市場は競合に満ちており、製品革新、パートナーシップの形成、市場拡大に注力する世界企業とローカル企業が混在しています。Thermo Fisher Scientific、Abbott、Bio-Rad Laboratories、Danaher Corporation（Beckman Coulter）、F. Hoffmann-La Roche Ltd.などの大手企業が最前線にいます。これらの企業は、ELISA検査の広範なポートフォリオと強力な世界販売網を持っています。これらの企業は研究開発に多額の投資を行い、より高感度で自動化され、臨床や研究用途に使いやすいELISAシステムを開発しています。Bio-Techne、RayBiotech、OriGene Technologies、Elabscienceのような新興・中堅企業も人気を集めています。これらの企業は特定の疾患領域をターゲットとし、カスタムアッセイ開発を提供しています。さらに、GenScript Biotech社やEurofins Scientific社のような企業は、アジア太平洋や欧州市場において、共同研究や現地製造への取り組みを通じて発展しています。

マルチプレックスELISA、ポータブルELISAプラットフォーム、自動化システムなどの技術革新が、この競合情勢をさらに形成しています。疾患の流行が増加し、早期診断の必要性が緊急性を増すにつれ、競合は激化しています。各社は、手頃な価格、スピード、正確さを重視しています。

目次

第1章 ELISA診断検査市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ELISA診断検査の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ELISA診断検査市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 ELISA診断検査市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 ELISA診断検査の市場情勢

  • ELISA診断検査の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ELISA診断検査市場：検査の種類別

  • 概要
    • セグメント別シェア分析：検査の種類別
    • 競合ELISA
    • 間接ELISA
    • マルチプル・ポータブルELISA
    • サンドイッチELISA

第8章 ELISA診断検査市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 免疫学
    • 炎症
    • 感染症
    • がん
    • タンパク質定量
    • その他の用途

第9章 ELISA診断検査市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院・診断センター
    • 製薬・バイオテクノロジー企業
    • 動物病院・診断検査室

第10章 ELISA診断検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：ELISA診断検査業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Abbott
    • Abcam Limited
    • BD
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • BioVision, Inc.
    • Creative Diagnostics
    • Danaher Corporation
    • Elabscience Biotechnology Inc.
    • Enzo Biochem, Inc.
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd
    • GenScript Biotech Corporation
    • Merck KGaA
    • MyBioSource, Inc.
    • OriGene Technologies, Inc.
    • PerkinElme.
    • RayBiotech, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV5445

REPORT HIGHLIGHT

ELISA Diagnostics Tests Market size was valued at US$ 1,690.32 Million in 2024, expanding at a CAGR of 5.93% from 2025 to 2032.

The global Enzyme-Linked Immunosorbent Assay (ELISA) market revolves around a diagnostic test designed to detect and measure antibodies in biological samples. By using this test, one can ascertain whether the sample has antibodies against or linked to a particular antigen associated with an infectious disease. As an immunogenic reaction to dangerous chemicals known as pathogens, proteins called antibodies are created to fight invading diseases. The biological process of ELISA involves the adsorption of an antigen onto a solid surface. An enzyme-linked antibody is permitted to be present with the antigen and is identified by the addition of an enzyme specific substrate. The ELISA test is crucial for diagnosing viral illnesses such syphilis, rotavirus, Zika virus, HIV, and the varicella zoster virus, which causes shingles and chickenpox. It is commonly used as a preliminary screening method before more detailed tests and also has applications in pharmaceutical quality control, including endotoxin detection and protein quantification.

ELISA Diagnostics Tests Market- Market Dynamics

Growing disease burden increases demand for early diagnostics

The rise of infectious and chronic diseases worldwide drives the need for early and accurate diagnostic methods. ELISA tests are vital because they can detect specific proteins, antigens, and antibodies early in the disease process. Companies like Thermo Fisher Scientific and Bio-Rad Laboratories commonly use ELISA kits for early HIV detection. This helps improve patient outcomes and reduce transmission. During the COVID-19 pandemic, Abbott created ELISA-based antibody tests to identify prior infections. This supported public health efforts and helped with vaccine distribution. Additionally, Bio-Techne provides ELISA kits for cancer biomarkers like PSA and CA-125. These kits aid in early diagnosis and treatment monitoring. These examples show how the rising number of diseases is increasing the global demand for ELISA diagnostic tests. Healthcare systems are focusing on sensitive, affordable, and reliable tools for early disease detection and management.

For Instance,

In October 2021, Siemens Healthineers launched a new ELISA-based assay designed for the early detection of autoimmune diseases, responding to the rising global prevalence of conditions like rheumatoid arthritis and lupus. This launch helps clinicians diagnose these complex diseases earlier, improving patient management.

ELISA Diagnostics Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.93% over the forecast period (2025-2032)

Based on test type segmentation, sandwich ELISA was predicted to show maximum market share in the year 2024

Based on application segmentation, infectious diseases was the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

ELISA Diagnostics Tests Market- Segmentation Analysis:

The global ELISA diagnostics tests market is segmented on the basis of test type, application, end user, and region.

The market is divided into four categories based on test type: competitive ELISA, indirect ELISA, multiple & portable ELISA, sandwich ELISA. The sandwich ELISA sector dominates the market. This is due to its superior sensitivity and specificity compared to other ELISA formats. This method involves capturing the target antigen between two layers of antibodies, which enhances the accuracy of detecting low concentrations of biomarkers in complex samples such as blood or serum. Because of these advantages, Sandwich ELISA is extensively used in clinical diagnostics for a wide range of applications including infectious disease detection, cancer biomarker identification, and hormone level measurement. Its reliability and ability to provide quantitative results make it the preferred choice among healthcare providers and research laboratories.

The market is divided into three categories based on end user: hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories. Hospitals & diagnostic centers dominates the market. This dominance is driven by the widespread use of ELISA tests in clinical settings for disease diagnosis, monitoring, and screening. Hospitals and diagnostic centers require reliable and rapid testing solutions to manage infectious diseases, chronic conditions, and other health concerns, making them the largest consumers of ELISA kits and related products. Their continuous demand for accurate and high throughput diagnostic tools ensures that this segment holds the largest market share compared to pharmaceutical companies and veterinary diagnostic laboratories.

ELISA Diagnostics Tests Market- Geographical Insights

North America dominates the global ELISA diagnostics tests market during the forecast period in 2024.

North America has the largest share in the ELISA Diagnostic Tests market. This is mainly due to its strong healthcare infrastructure and high volumes of diagnostic testing. The region benefits from significant government and private sector investment in medical research and public health. Major players like Thermo Fisher Scientific, Abbott, and Bio-Rad Laboratories drive ongoing innovation and the availability of quality ELISA kits and instruments. Hospitals and labs throughout the U.S. and Canada commonly use ELISA tests to diagnose a variety of infectious and chronic diseases. Moreover, a high level of awareness about early disease detection and favourable reimbursement policies help support widespread use of these tests. Together, these factors make North America the leading region in this market.

Asia Pacific is estimated to register the highest CAGR in the ELISA diagnostics tests market during the forecast period in 2024.

The Asia-Pacific region is seeing the fastest growth in the ELISA Diagnostic Tests market. This growth is due to an increase in infectious and lifestyle related diseases. Countries such as China, India, and Southeast Asian nations are expanding their healthcare infrastructure and investing more in diagnostic technologies. There is a rising awareness among healthcare professionals and the public about the importance of early diagnosis, which is increasing the demand for ELISA-based tests. Government health initiatives and large screening programs are also promoting the use of reliable diagnostic tools like ELISA. Furthermore, the low cost of ELISA kits makes them a popular option in budget-conscious healthcare settings. These factors are driving significant market growth in the region.

ELISA Diagnostics Tests Market- Competitive Landscape:

The ELISA Diagnostic Tests market is filled with competition, featuring a mix of global and local players focused on product innovation, forming partnerships, and expanding their reach. Major names like Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter), and F. Hoffmann-La Roche Ltd. are at the forefront. They have extensive portfolios of ELISA tests and strong global distribution networks. These companies invest heavily in research and development to create ELISA systems that are more sensitive, automated, and user-friendly for clinical and research applications. Emerging and mid-sized companies like Bio-Techne, RayBiotech, OriGene Technologies, and Elabscience are also gaining traction. They target specific disease areas and offer custom assay development. Additionally, firms like GenScript Biotech and Eurofins Scientific are evolving in the Asia-Pacific and European markets through collaborations and local manufacturing efforts.

Technological innovations, such as multiplex ELISA, portable ELISA platforms, and automation systems, further shape this competitive landscape. As disease prevalence increases and the need for early diagnosis becomes urgent, the competition intensifies. Companies are focusing on affordability, speed, and accuracy.

Recent Developments:

In May 2024, Merck KGaA announced the acquisition of Mirus Bio for approximately USD 600 million. While focused on viral vector manufacturing, the acquisition strengthens Merck's downstream analytics capabilities, including ELISA-based platforms. This deal supports the company's strategic vision to enhance its life sciences portfolio and advance solutions in gene therapy and bioprocessing diagnostics

In April 2023, Thermo Fisher Scientific Inc. introduced a next-generation ELISA kit platform aimed at providing enhanced sensitivity and faster results for both clinical and research settings. The new kits incorporate advanced signal detection technology, which shortens assay times and improves consistency across various biomarker analyses. This launch highlights Thermo Fisher's ongoing commitment to advancing diagnostic precision and operational efficiency in laboratories around the globe

In February 2023, Abcam plc expanded its ELISA product portfolio with the launch of a new range of recombinant monoclonal antibody-based ELISA kits. Designed for cancer and autoimmune disease research, these kits deliver enhanced specificity and consistency across experiments. The launch underscores Abcam's commitment to reproducibility and high-quality research tools, supporting the advancing needs of academic and biopharmaceutical research communities

In February 2023, Merck KGaA through its life science division MilliporeSigma, launched multiplex ELISA kits specifically designed for detecting cytokines and chemokines in preclinical research. These kits enable the simultaneous measurement of multiple analytes, improving both data depth and assay efficiency. This launch enhances Merck's presence in the diagnostic and life sciences space, aligning with the growing demand for advanced tools in biomarker discovery and translational research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELISA DIAGNOSTICS TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Abcam Limited
  • BD
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioVision, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • Elabscience Biotechnology Inc.
  • Enzo Biochem, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Merck KGaA
  • MyBioSource, Inc.
  • OriGene Technologies, Inc.
  • PerkinElme.
  • RayBiotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Competitive ELISA
  • Indirect ELISA
  • Multiple & Portable ELISA
  • Sandwich ELISA

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Other Applications

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Veterinary Hospitals & Diagnostic Laboratories

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. ELISA Diagnostics Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. ELISA Diagnostics Tests Market Snippet by Test Type
    • 2.1.2. ELISA Diagnostics Tests Market Snippet by Application
    • 2.1.3. ELISA Diagnostics Tests Market Snippet by End User
    • 2.1.4. ELISA Diagnostics Tests Market Snippet by Country
    • 2.1.5. ELISA Diagnostics Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. ELISA Diagnostics Tests Key Market Trends

  • 3.1. ELISA Diagnostics Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. ELISA Diagnostics Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. ELISA Diagnostics Tests Market Opportunities
  • 3.4. ELISA Diagnostics Tests Market Future Trends

4. ELISA Diagnostics Tests Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ELISA Diagnostics Tests Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. ELISA Diagnostics Tests Market Landscape

  • 6.1. ELISA Diagnostics Tests Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. ELISA Diagnostics Tests Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Competitive ELISA
    • 7.1.3. Indirect ELISA
    • 7.1.4. Multiple & Portable ELISA
    • 7.1.5. Sandwich ELISA

8. ELISA Diagnostics Tests Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Immunology
    • 8.1.3. Inflammation
    • 8.1.4. Infectious diseases
    • 8.1.5. Cancer
    • 8.1.6. Protein quantification
    • 8.1.7. Other Applications

9. ELISA Diagnostics Tests Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Diagnostic Centers
    • 9.1.3. Pharmaceutical & Biotechnology Companies
    • 9.1.4. Veterinary Hospitals & Diagnostic Laboratories

10. ELISA Diagnostics Tests Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. ELISA Diagnostics Tests Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. ELISA Diagnostics Tests Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. ELISA Diagnostics Tests Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. ELISA Diagnostics Tests Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. ELISA Diagnostics Tests Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- ELISA Diagnostics Tests Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Abcam Limited
    • 11.2.3. BD
    • 11.2.4. Bio-Rad Laboratories, Inc.
    • 11.2.5. Bio-Techne Corporation
    • 11.2.6. BioVision, Inc.
    • 11.2.7. Creative Diagnostics
    • 11.2.8. Danaher Corporation
    • 11.2.9. Elabscience Biotechnology Inc.
    • 11.2.10. Enzo Biochem, Inc.
    • 11.2.11. Eurofins Scientific SE
    • 11.2.12. F. Hoffmann-La Roche Ltd
    • 11.2.13. GenScript Biotech Corporation
    • 11.2.14. Merck KGaA
    • 11.2.15. MyBioSource, Inc.
    • 11.2.16. OriGene Technologies, Inc.
    • 11.2.17. PerkinElme.
    • 11.2.18. RayBiotech, Inc.
    • 11.2.19. Siemens Healthineers AG
    • 11.2.20. Thermo Fisher Scientific Inc.
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us